IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
47 hedge funds and large institutions have $99.8M invested in Ibere Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+9
Holders Change %
+23.68%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
8
Reduced
2
Closed
3
Calls
$114K
Puts
–
Net Calls
+$114K
Net Calls Change
+$25K
Top Buyers
1 |
![]()
Brown Advisory
Baltimore,
Maryland
|
$11.7M |
2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
$3.27M |
3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
$2.71M |
4 |
D.E. Shaw & Co
New York
|
$3.93M |
5 |
GCL
Glazer Capital LLC
New York
|
$1.81M |